← Leaderboards
Rachel Kulberg
Kepley Biosystems Incorporated
$1,481,068
Attributed
$1,481,068
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2021–22$2M$1.5M$1M$500K$0
'21
'22
Funding mix
By agency
NSF$1,481,068 · 2
By mechanism
—$1,481,068 · 2
Top collaborators
No co-investigators on record.
Grant awards (2)
SBIR Phase II: A Rapid, Sensitive Pathogen Typing and Antibiotic Sensitivity Test for Bloodstream Infections (COVID-19)$1,225,234
· FY2022 · TIP · contact PI
SBIR Phase I: A Rapid, Sensitive Pathogen Typing and Antibiotic Sensitivity Test for Bloodstream Infections (COVID-19)$255,834
· FY2021 · TIP · contact PI